Delivery Order 75FCMC23D0004-75F40124F80369

Award Date 9/25/24
Potential Completion Date 9/29/25
Potential Value $964K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West McLean, VA 22102, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-plus-fixed-fee delivery order contract awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit research and development organization, for $1,007,126.00. The contract is for the FDA's Center for Drug Evaluation and Research (CDER) to develop innovative prescriber education materials related to the Risk Evaluation and Mitigation Strategy (REMS) program. The contract has no set-aside designation. Mitre is the prime contractor and will leverage its...
This is a Cost Plus Fixed Fee delivery order awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a not-for-profit federally funded research and development center (FFRDC). The $649,894 contract provides strategic and technical engineering support for the FDA's Office of Regulatory Affairs (ORA) Foreign Inspection Program System, including requirements verification, potential solutions, and prototype development. The contract is not set aside and is part of Mitre's $2...
This is a $999,876.00 cost-plus-fixed-fee delivery order awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The contract has a period of performance ending on September 29, 2027. The contract does not have a set-aside designation. As an FFRDC, Mitre specializes in systems engineering, information technology, cybersecurity, enterprise modernization, and strategic advisory...
This federal contract award was made by the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The contract, valued at $3,085,259.00, is for the provision of strategic services in support of human drug advisory committee modernization efforts. It is a cost-plus-fixed-fee delivery order contract with no set-aside designation. Mitre, as the...
This federal contract award was issued by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The contract, valued at $1,253,650.78, is a cost-plus-fixed-fee delivery order for strategic engineering support, data standards, and harmonization services for the Office of the Chief Scientist and the Office of Health Informatics. The contract does not have a set-aside designation. The...
The Department of Health and Human Services Food and Drug Administration awarded a $499,998.00 cost-plus-fixed-fee delivery order contract to The Mitre Corporation, a not-for-profit organization, for the "OFFICE OF HEALTH INFORMATIC DATA STANDARDIZATION AND INFORMATION" effort. The contract does not have a set-aside designation and was completed on September 29, 2020. Mitre, which operates federally funded research and development centers to provide technical expertise to the...
This is a federal contract award to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs), to provide systems engineering and technical acquisitions support services to the U.S. Food and Drug Administration (FDA). The contract has a ceiling value of $5,859,996.00 and runs from September 30, 2015 to December 21, 2016. It is a Cost Plus Fixed Fee contract type. The Mitre Corporation has been awarded multiple federal contracts...
This federal contract award was issued by the Food and Drug Administration (FDA) to The Mitre Corporation, a not-for-profit organization that operates federally funded research and development centers (FFRDCs). The $170,441.38 Delivery Order contract is for the OFFICE OF INFORMATION MANAGEMENT AND TECHNOLOGY VITAL AND ESSENTIAL RECORDS MANAGEMENT PROGRAM, and has a completion date of March 24, 2017. The contract type is Cost Plus Fixed Fee, and there is no set-aside designation. Mitre, the prime...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a not-for-profit organization that operates federally funded research and development centers (FFRDCs). The $4,427,933.97 cost-plus-fixed-fee contract supports the Center for Devices and Radiological Health (CDRH) Case for Quality strategic initiatives under the Centers for Medicare & Medicaid Services (CMS) Alliance to Modernize Healthcare (CAMH) FFRDC. The contract does not have...
This is a $2,428,805.48 cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization, for technical support services to the FDA's Center for Drug Evaluation and Research (CDER) governance strategy and implementation. The contract does not have a set-aside designation and was awarded on June 8, 2018, with a completion date of September 26, 2019. The Mitre Corporation...
  • 75FCMC23D0004
    Indefinite Delivery Contract
  • 75FCMC23D0004-75F40124F80369
    Delivery Order

This is a federal contract award from the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). The $964,222 contract is a Cost Plus Fixed Fee Delivery Order issued under a $2 billion single-award Indefinite Delivery Vehicle (IDV) contract with the Centers for Medicare and Medicaid Services (CMS) for the CMS Alliance to Modernize Healthcare (HEALTH) FFRDC.

The contract is focused on FDA Risk Evaluation and Mitigation Strategies (REMS) integration pilots for Fiscal Years 2024-2025. Mitre will partner with Invaryant Inc., a for-profit company, to implement a FHIR-based use case under the Codex initiative, part of the HL7 FHIR Accelerator, to streamline REMS-related administrative burdens. This effort aims to create an interoperable REMS ecosystem to improve access to critical medications. The contract does not have a set-aside designation.

Generated 12/6/24, 9:20 AM